MRC ALL 97 - UK national lymphoblastic leukaemia (ALL) trial
Completed
- Conditions
- eukaemiaCancerLymphoblastic leukaemia
- Registration Number
- ISRCTN26727615
- Lead Sponsor
- Medical Research Council (MRC) (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 1800
Inclusion Criteria
Open to all children with ALL except those in 'Exclusions'
Exclusion Criteria
1. Patients under 1 year or over 18 years,
2. B-ALL, Ph positivity, near haploidy in blasts or rearrangements involving the MLL gene on 11q23 and
3. High risk by Oxford Hazard Score (based on a function of age, gender and diagnostic leucocyte count)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Disease-free survival<br>2. CNS disease eradication<br>3. Relapse rates
- Secondary Outcome Measures
Name Time Method ot provided at time of registration